Triterpenoids as new promising anticancer drugs.

Triterpenoids are structurally diverse organic compounds, characterized by a basic backbone modified in multiple ways, allowing the formation of more than 20 000 naturally occurring triterpenoid varieties. Several triterpenoids, including ursolic and oleanolic acid, betulinic acid, celastrol, pristimerin, lupeol, and avicins possess antitumor and anti-inflammatory properties. To improve antitumor activity, some synthetic triterpenoid derivatives have been synthesized, including cyano-3,12-dioxooleana-1,9 (11)-dien-28-oic (CDDO), its methyl ester (CDDO-Me), and imidazolide (CDDO-Im) derivatives. Of these, CDDO, CDDO-Me, and betulinic acid have shown promising antitumor activities and are presently under evaluation in phase I studies. Triterpenoids are highly multifunctional and the antitumor activity of these compounds is measured by their ability to block nuclear factor-kappaB activation, induce apoptosis, inhibit signal transducer, and activate transcription and angiogenesis.

[1]  M. Sporn,et al.  The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid-Imidazolide Alters Transforming Growth Factor β-dependent Signaling and Cell Migration by Affecting the Cytoskeleton and the Polarity Complex* , 2008, Journal of Biological Chemistry.

[2]  S. Ramaiah,et al.  Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. , 2007, Cancer research.

[3]  S. Dulchavsky,et al.  CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells. , 2008, Journal of experimental therapeutics & oncology.

[4]  M. Sporn,et al.  Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice , 2009, Proceedings of the National Academy of Sciences.

[5]  M. Sporn,et al.  CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha. , 2007, Blood.

[6]  Y. Shukla,et al.  Retracted: Prasad, S., Nigam, N., Kalra, N. and Shukla, Y. (2008), Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells. Mol. Carcinog., 47: 916‐924. https://doi.org/10.1002/mc.20442 , 2008, Molecular carcinogenesis.

[7]  J. Gutterman,et al.  Avicins: Triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Gold,et al.  Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. , 2003, Cancer research.

[9]  M. Sporn,et al.  The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[11]  Youcheng Zhang,et al.  Lupeol, a Dietary Triterpene, Inhibited Growth, and Induced Apoptosis Through Down-Regulation of DR3 in SMMC7721 Cells , 2009, Cancer investigation.

[12]  M. Strnad,et al.  Synthesis of lupane-type saponins bearing mannosyl and 3,6-branched trimannosyl residues and their evaluation as anticancer agents. , 2008, Carbohydrate research.

[13]  A. Hardikar,et al.  Human Blood Vessel–Derived Endothelial Progenitors for Endothelialization of Small Diameter Vascular Prosthesis , 2009, PloS one.

[14]  A. Pichette,et al.  Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents. , 2006, Bioorganic & medicinal chemistry.

[15]  Young-Soo Hong,et al.  Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. , 2006, Biochemical pharmacology.

[16]  K. Hata,et al.  Differentiation- and apoptosis-inducing activities by pentacyclic triterpenes on a mouse melanoma cell line. , 2002, Journal of natural products.

[17]  M. Sporn,et al.  The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent , 2007, Molecular Cancer Therapeutics.

[18]  D. Kufe,et al.  Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179. , 2006, The Journal of biological chemistry.

[19]  J. Gutterman,et al.  Avicin D: A Protein Reactive Plant Isoprenoid Dephosphorylates Stat 3 by Regulating Both Kinase and Phosphatase Activities , 2009, PloS one.

[20]  K. P. Mishra,et al.  Betulinic acid induces apoptosis in human chronic myelogenous leukemia (CML) cell line K-562 without altering the levels of Bcr-Abl. , 2005, Toxicology letters.

[21]  M. Sporn,et al.  The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis , 2008, Molecular Cancer Therapeutics.

[22]  S. Shukla,et al.  Betulinic acid suppresses constitutive and TNFα‐induced NF‐κB activation and induces apoptosis in human prostate carcinoma PC‐3 cells , 2008, Molecular carcinogenesis.

[23]  Marita Hernández,et al.  Acidic triterpenes compromise growth and survival of astrocytoma cell lines by regulating reactive oxygen species accumulation. , 2007, Cancer research.

[24]  S. Bernstein,et al.  The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway. , 2006, Experimental hematology.

[25]  M. Sporn,et al.  Prevention and Treatment of Experimental Estrogen Receptor – Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268 , 2008, Clinical Cancer Research.

[26]  M. Sporn,et al.  c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells , 2004, Cancer Research.

[27]  J. Keats,et al.  Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. , 2008, Blood.

[28]  M. Andreeff,et al.  Phase I trial with a novel oral NF-{kappa}B/STAT3 inhibitor RTA 402 in patients with solid tumors and lymphoid malignancies , 2008 .

[29]  M. Sporn,et al.  Efficient synthesis of (-)- and (+)-tricyclic compounds with enone functionalities in rings A and C. A novel class of orally active anti-inflammatory and cancer chemopreventive agents. , 2003, Organic & biomolecular chemistry.

[30]  M. Sporn,et al.  The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism. , 2001, Molecular pharmacology.

[31]  M. Sporn,et al.  Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer , 2007, Nature Reviews Cancer.

[32]  M. Sporn,et al.  The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. , 2005, Cancer research.

[33]  T. Golub,et al.  Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.

[34]  J. Pezzuto,et al.  Betulinic acid induces apoptosis in human neuroblastoma cell lines. , 1997, European journal of cancer.

[35]  M. Sporn,et al.  Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels. , 2008, Leukemia research.

[36]  J. Gutterman,et al.  Triterpenoid Electrophiles (Avicins) Suppress Heat Shock Protein-70 and X-Linked Inhibitor of Apoptosis Proteins in Malignant Cells by Activation of Ubiquitin Machinery: Implications for Proapoptotic Activity , 2005, Clinical Cancer Research.

[37]  M. Sporn,et al.  Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes , 2006, Molecular Cancer Therapeutics.

[38]  G. Mills,et al.  Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis. , 2001, Cancer research.

[39]  M. Cascante,et al.  (2α,3β)‐2,3‐Dihydroxyolean‐12‐en‐28‐oic acid, a new natural triterpene from Olea europea, induces caspase dependent apoptosis selectively in colon adenocarcinoma cells , 2006 .

[40]  B. Fadeel,et al.  Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma‐derived B‐cell lines , 2006, International journal of cancer.

[41]  M. Sporn,et al.  High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide. , 2009, Cancer letters.

[42]  J Liu,et al.  Pharmacology of oleanolic acid and ursolic acid. , 1995, Journal of ethnopharmacology.

[43]  H. Mukhtar,et al.  Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis , 2008, Clinical Cancer Research.

[44]  M. Sporn,et al.  c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells , 2007, Cancer biology & therapy.

[45]  V. Adhami,et al.  Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. , 2005, Carcinogenesis.

[46]  A. Kong,et al.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. , 2008, Biochemical pharmacology.

[47]  Monica L Guzman,et al.  Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. , 2008, Blood.

[48]  M. Sporn,et al.  The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia , 2004, Cancer Research.

[49]  B. Bartel,et al.  Biosynthetic diversity in plant triterpene cyclization. , 2006, Current opinion in plant biology.

[50]  J. Gutterman,et al.  Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-κB by inhibiting both its nuclear localization and ability to bind DNA , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Kwak,et al.  Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance. , 2008, Cancer letters.

[52]  H. Kwon,et al.  Betulinic Acid Inhibits Growth Factor‐induced in vitro Angiogenesis via the Modulation of Mitochondrial Function in Endothelial Cells , 2002, Japanese journal of cancer research : Gann.

[53]  M. Sporn,et al.  The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-κB activation through direct inhibition of IκB kinase β , 2006, Molecular Cancer Therapeutics.

[54]  Paul Talalay,et al.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Krajewski,et al.  Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma , 2007, Clinical Cancer Research.

[56]  Y. Rojanasakul,et al.  Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. , 2010, Biochemical pharmacology.

[57]  M. Sporn,et al.  A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. , 2001, Arthritis and rheumatism.

[58]  M. Konopleva,et al.  A Synthetic Triterpenoid, CDDO-Me, Inhibits IκBα Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor κB–Regulated Gene Products in Human Leukemic Cells , 2006, Clinical Cancer Research.

[59]  J. Gutterman,et al.  Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. , 2008, The Journal of investigative dermatology.

[60]  M. Sporn,et al.  The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance. , 2004, Blood.

[61]  M. Sporn,et al.  Human neuroblastoma cells rapidly enter cell cycle arrest and apoptosis following exposure to C-28 derivatives of the synthetic triterpenoid CDDO , 2008, Cancer biology & therapy.

[62]  M. Sporn,et al.  2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer* , 2005, Journal of Biological Chemistry.

[63]  M. Sporn,et al.  Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities , 2007, Molecular Cancer Therapeutics.

[64]  M. Konopleva,et al.  Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells , 2006, Molecular Cancer Therapeutics.

[65]  Tadashi Honda,et al.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. , 2002, Blood.

[66]  M. Sporn,et al.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. , 2007, Antioxidants & redox signaling.

[67]  M. Sporn,et al.  The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[68]  Yasuyuki Kosaka,et al.  Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell line , 2007, Cytotechnology.

[69]  P. Fisher,et al.  Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer. , 2008, Cancer research.

[70]  M. Sporn,et al.  Design and synthesis of tricyclic compounds with enone functionalities in rings A and C: a novel class of highly active inhibitors of nitric oxide production in mouse macrophages. , 2002, Journal of medicinal chemistry.

[71]  Youxin Zhou,et al.  [Several monomes from Tripterygium wilfordii inhibit proliferation of glioma cells in vitro]. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[72]  Gaosi Xu,et al.  Tripterygium wilfordii Hook F Treatment for Idiopathic Refractory Nephrotic Syndrome in Adults: A Meta-Analysis , 2009, Nephron Clinical Practice.

[73]  D. Kufe,et al.  Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179* , 2006, Journal of Biological Chemistry.

[74]  J. Issa,et al.  PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL , 2007, Cancer biology & therapy.

[75]  N. Sakato,et al.  Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol , 2003, Bioscience, biotechnology, and biochemistry.

[76]  M. Konopleva,et al.  Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells , 2008, Molecular Cancer Therapeutics.

[77]  Stephen S. Hecht,et al.  Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers , 2009, Nature Reviews Cancer.

[78]  V. Adhami,et al.  A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. , 2005, Cancer research.

[79]  M. Konopleva,et al.  The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. , 2007, Cancer research.

[80]  M. Sporn,et al.  A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin. , 2008, Cancer research.

[81]  S. Dulchavsky,et al.  Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-κB and Notch1 signaling , 2007, Journal of Neuro-Oncology.

[82]  W. Dalton,et al.  Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR. , 2001, Molecular cancer therapeutics.

[83]  M. Artwohl,et al.  Chemical modulation of VLA integrin affinity in human breast cancer cells. , 2007, Experimental cell research.

[84]  J. Gutterman,et al.  A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase , 2007, Cell Death and Differentiation.

[85]  A. Pichette,et al.  Synthesis and structure-activity relationship study of cytotoxic germanicane- and lupane-type 3beta-O-monodesmosidic saponins starting from betulin. , 2007, Bioorganic & medicinal chemistry.

[86]  M. Sporn,et al.  The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells , 2006, Molecular Cancer Therapeutics.

[87]  Manoj Kumar Gupta,et al.  Mechanism and its regulation of tumor-induced angiogenesis. , 2003, World journal of gastroenterology.

[88]  B. Aggarwal,et al.  Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. , 2007, Blood.

[89]  H. Mankin,et al.  CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells , 2009, Cancer Chemotherapy and Pharmacology.

[90]  M. Sporn,et al.  Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. , 2006, Cancer research.

[91]  V. Adhami,et al.  Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. , 2009, Cancer research.

[92]  D. Gold,et al.  Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. , 2003, Cancer research.

[93]  B. Eisenberg,et al.  The Synthetic Triterpenoid CDDO-Im Inhibits Fatty Acid Synthase Expression and Has Antiproliferative and Proapoptotic Effects in Human Liposarcoma Cells , 2008, Cancer investigation.

[94]  N. Kikuchi,et al.  Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer , 2009, Clinical Cancer Research.

[95]  Jia Luo,et al.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. , 2009, Cancer letters.

[96]  M. Sporn,et al.  Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids. , 2008, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[97]  J. Gutterman,et al.  Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. , 2004, The Journal of clinical investigation.

[98]  M. Sporn,et al.  The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells , 2006, Clinical Cancer Research.

[99]  M. Sporn,et al.  Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids. , 2008, Cancer research.

[100]  W. Rzeski,et al.  Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[101]  M. Konopleva,et al.  2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid and Related Compounds Inhibit Growth of Colon Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Dependent and -Independent Pathways , 2005, Molecular Pharmacology.

[102]  S. Shukla,et al.  Dietary Agents in the Chemoprevention of Prostate Cancer , 2005, Nutrition and cancer.

[103]  M. Sporn,et al.  Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid. , 2004, Molecular cancer therapeutics.

[104]  F. Khuri,et al.  Depletion of ntracellular Glutathione Contributes to JNK-Mediated Death Receptor 5 Upregulation and Apoptosis Induction by the Novel Synthetic Triterpenoid Methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me)1 , 2006, Cancer biology & therapy.

[105]  S. Dulchavsky,et al.  Oleanane Triterpenoid CDDO‐Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro‐survival Akt and mTOR , 2009, The Prostate.

[106]  M. Konopleva,et al.  A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[107]  M. Konopleva,et al.  The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore. , 2007, Cancer research.

[108]  M. Konopleva,et al.  Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies , 2007 .

[109]  I. Jeremias,et al.  Betulinic acid-induced apoptosis in leukemia cells , 2004, Leukemia.

[110]  J. Medema,et al.  Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion , 2009, Apoptosis.

[111]  M. Sporn,et al.  The triterpenoid CDDO induces apoptosis in refractory CLL B cells. , 2002, Blood.

[112]  M. Sporn,et al.  The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance. , 2003, Cancer research.

[113]  S. Srivastava,et al.  Betulinic acid and its derivatives as anti-angiogenic agents. , 2004, Bioorganic & medicinal chemistry letters.

[114]  Fernando J. Reyes-Zurita,et al.  Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. , 2009, Cancer letters.

[115]  M. Sporn,et al.  The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta. , 2006, Molecular cancer therapeutics.

[116]  M. Konopleva,et al.  A Novel Mechanism of Action of Methyl-2-cyano-3,12 Dioxoolean-1,9 Diene-28-oate: Direct Permeabilization of the Inner Mitochondrial Membrane to Inhibit Electron Transport and Induce Apoptosis , 2005, Molecular Pharmacology.

[117]  Young-Soo Hong,et al.  Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinone methide triterpenoid , 2006 .

[118]  Di Chen,et al.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. , 2006, Cancer research.

[119]  M. Sporn,et al.  The Novel Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) Potently Enhances Apoptosis Induced by Tumor Necrosis Factor in Human Leukemia Cells* , 2002, The Journal of Biological Chemistry.